tradingkey.logo

Alpha Teknova Inc

TKNO

4.340USD

+0.100+2.36%
交易中 美東報價延遲15分鐘
231.92M總市值
虧損本益比TTM

Alpha Teknova Inc

4.340

+0.100+2.36%
關於 Alpha Teknova Inc 公司
Alpha Teknova, Inc. 是治療、疫苗和分子診斷研究、發現、開發和商業化關鍵試劑的生產商。該公司提供兩條主要業務線,包括實驗室必需品和臨牀解決方案。該公司還提供三種主要產品類型:用於細胞生長和克隆的預灌裝培養基板;用於細胞擴增的液體細胞培養基和補充劑;以及用於樣品處理、再懸浮和純化的分子生物學試劑。該公司在其兩個產品類別中都提供液體細胞培養基和補充劑以及分子生物學試劑;預灌裝培養基板僅在其實驗室必需品類別中提供。其客戶包括製藥和生物技術公司、合同開發和製造組織、體外診斷特許經營商以及開發疫苗和治療並進行基礎研究的學術和政府研究機構。
公司簡介
公司代碼TKNO
公司名稱Alpha Teknova Inc
上市日期Jun 25, 2021
CEOMr. Stephen Gunstream
員工數量173
證券類型Ordinary Share
年結日Jun 25
公司地址2451 Bert Drive
城市HOLLISTER
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編95023
電話18316371100
網址https://www.teknova.com/
公司代碼TKNO
上市日期Jun 25, 2021
CEOMr. Stephen Gunstream
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+13.39%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+74.98%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-24.19%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--
Mr. Alexander C. Herzick
Mr. Alexander C. Herzick
Director
Director
--
--
Ms. Brett M. Robertson
Ms. Brett M. Robertson
Independent Director
Independent Director
--
--
Mr. J. Matthew Mackowski
Mr. J. Matthew Mackowski
Director
Director
--
--
Mr. Matthew C. Lowell
Mr. Matthew C. Lowell
Chief Financial Officer
Chief Financial Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+13.39%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+74.98%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-24.19%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Lab Essentials
8.12M
82.87%
Clinical Solutions
1.16M
11.86%
Other
516.00K
5.27%
地區USD
名稱
營收
佔比
United States
9.27M
94.66%
International
523.00K
5.34%
業務
地區
業務USD
名稱
營收
佔比
Lab Essentials
8.12M
82.87%
Clinical Solutions
1.16M
11.86%
Other
516.00K
5.27%
股東統計
更新時間: 7月9日 週三
更新時間: 7月9日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Telegraph Hill Partners
70.58%
Davis (Ted)
3.53%
Davis (Irene)
3.16%
UBS Financial Services, Inc.
2.17%
Balyasny Asset Management LP
1.57%
Other
19.00%
持股股東
持股股東
佔比
Telegraph Hill Partners
70.58%
Davis (Ted)
3.53%
Davis (Irene)
3.16%
UBS Financial Services, Inc.
2.17%
Balyasny Asset Management LP
1.57%
Other
19.00%
股東類型
持股股東
佔比
Private Equity
70.58%
Individual Investor
10.77%
Investment Advisor
5.23%
Hedge Fund
3.12%
Investment Advisor/Hedge Fund
2.40%
Research Firm
0.82%
Pension Fund
0.15%
Other
6.93%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
131
49.74M
93.07%
-991.18K
2025Q1
159
49.02M
94.72%
+9.59M
2024Q4
142
49.19M
92.33%
+11.09M
2024Q3
142
47.90M
89.93%
+8.81M
2024Q2
140
36.69M
87.73%
-3.53M
2024Q1
145
36.60M
90.14%
-2.50M
2023Q4
149
35.47M
91.35%
-3.28M
2023Q3
155
35.09M
90.51%
+4.53M
2023Q2
176
26.14M
92.65%
-5.67M
2023Q1
173
27.23M
97.10%
+13.65M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Telegraph Hill Partners
37.72M
70.58%
--
--
Apr 22, 2025
Davis (Ted)
1.89M
3.53%
--
--
Apr 22, 2025
Davis (Irene)
1.69M
3.16%
--
--
Apr 22, 2025
UBS Financial Services, Inc.
1.16M
2.17%
+46.45K
+4.17%
Mar 31, 2025
Balyasny Asset Management LP
836.96K
1.57%
-164.71K
-16.44%
Mar 31, 2025
Mackowski J Matthew
820.81K
1.54%
--
--
Apr 22, 2025
Lowell (Matthew)
820.81K
1.54%
+701.77K
+589.51%
Apr 22, 2025
The Vanguard Group, Inc.
573.45K
1.07%
+33.21K
+6.15%
Mar 31, 2025
CenterBook Partners LP
304.55K
0.57%
+304.55K
--
Mar 31, 2025
Wexford Capital LP
275.00K
0.51%
+275.00K
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
ProShares Nanotechnology ETF
0.6%
Invesco Nasdaq Biotechnology ETF
0.03%
ProShares Ultra Nasdaq Biotechnology
0.03%
iShares Micro-Cap ETF
0.01%
iShares Biotechnology ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
iShares Russell 2000 Growth ETF
0%
ProShares UltraPro Russell2000
0%
查看更多
ProShares Nanotechnology ETF
佔比0.6%
Invesco Nasdaq Biotechnology ETF
佔比0.03%
ProShares Ultra Nasdaq Biotechnology
佔比0.03%
iShares Micro-Cap ETF
佔比0.01%
iShares Biotechnology ETF
佔比0.01%
Dimensional US Core Equity 1 ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%
Invesco Dorsey Wright SmallCap Momentum ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
分紅派息
近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI